1. Home
  2. TCPC vs TECX Comparison

TCPC vs TECX Comparison

Compare TCPC & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock TCP Capital Corp.

TCPC

BlackRock TCP Capital Corp.

HOLD

Current Price

$5.54

Market Cap

449.7M

Sector

Finance

ML Signal

HOLD

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$20.96

Market Cap

359.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCPC
TECX
Founded
2006
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
449.7M
359.0M
IPO Year
2012
2018

Fundamental Metrics

Financial Performance
Metric
TCPC
TECX
Price
$5.54
$20.96
Analyst Decision
Sell
Strong Buy
Analyst Count
2
5
Target Price
$6.50
$81.20
AVG Volume (30 Days)
1.0M
319.1K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
22.30%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$219,119,058.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.29
$13.70
52 Week High
$9.48
$61.07

Technical Indicators

Market Signals
Indicator
TCPC
TECX
Relative Strength Index (RSI) 42.63 55.95
Support Level $5.29 $20.54
Resistance Level $5.76 $22.00
Average True Range (ATR) 0.15 1.10
MACD -0.03 0.08
Stochastic Oscillator 28.49 75.30

Price Performance

Historical Comparison
TCPC
TECX

About TCPC BlackRock TCP Capital Corp.

BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: